Phanicare Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Shaikpet, Telangana, India, established in 2003.
2003 Shaikpet, Telangana, India Active
Last Updated:
Access Report
About Phanicare Pharmaceuticals Private Limited

Phanicare Pharmaceuticals Private Limited, a active private limited company, was established on 07 October 2003 in Shaikpet, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2003PTC041815. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.30 Cr.

It upholds a compliant status. Employing 1 professional, Its leadership includes Sumanth Karlapudi (Director), Vishnuvardhan Reddy Devireddy (Director), Mallikarjuna Reddy Venati (Director). Past directors included Srinivasa Rao Chandolu, Janakamma Chandolu, Sumanth Karlapudi. It holds ₹16.61 Cr open charges and ₹12.66 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit S1, 2Nd Fllor, 36 Square Building, Jubilee Hills, Shaikpet, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2003PTC041815

  • Registration Number

    041815

  • Incorporation Date

    07 October 2003

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹3.30 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 3.30 Cr
  • Company Age 22 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 16.61 Cr
  • Satisfied Charges ₹ 12.66 Cr
  • Revenue Growth **** 55.11%
  • Profit Growth **** 34.24%
  • Ebitda **** 26.15%
  • Net Worth 28.09%
  • Total Assets **** 26.63%
Company report

Phanicare Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Phanicare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Phanicare Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumanth Karlapudi Director 01 Oct 2022 Current
Vishnuvardhan Reddy Devireddy Director 08 Apr 2015 Current
Mallikarjuna Reddy Venati Director 08 Apr 2015 Current
Padma Duvvuri Director 21 Apr 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 26 Oct 2015 Past
Pramod Abcsdd Director 26 Oct 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 01 Oct 2015 Past
Pramod Abcsdd Additional Director 01 Oct 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Phanicare Pharmaceuticals.

Phanicare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.11% increase. The company also saw a substantial improvement in profitability, with a 34.24% increase in profit. The company's net worth Soared by an impressive increase of 28.09%.

Phanicare Pharmaceuticals revenue growth over time
Phanicare Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 55.11%
*******
*******
*******
*******
Revenue from Operations
*******
 55.10%
*******
*******
*******
*******
Total Assets
*******
 26.63%
*******
*******
*******
*******
Profit or Loss
*******
 34.24%
*******
*******
*******
*******
Net Worth
*******
 28.09%
*******
*******
*******
*******
EBITDA
*******
 26.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Phanicare Pharmaceuticals?

In 2023, Phanicare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹166,084,000.00

Satisfied Charges

₹126,600,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 16.61 Cr
Latest Charge Details
Date Lender Amount Status
30 Sep 2023 Axis Bank Limited ₹3.50 Cr Open
01 Jul 2020 Axis Bank Limited ₹1.61 Cr Open
04 Oct 2018 Axis Bank Limited ₹11.50 Cr Open
09 Apr 2020 Axis Bank Limited ₹4.00 M Satisfied
17 Jul 2017 Axis Bank Limited ₹3.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Phanicare Pharmaceuticals?

Phanicare Pharmaceuticals has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Phanicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phanicare Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Phanicare Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Phanicare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Phanicare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 3.50 Cr registered on 30 Sep 2023 with Charge ID 100803453 was modified on 29 Feb 2024. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 3.50 Cr with Charge ID 100803453 was registered on 30 Sep 2023. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 11.50 Cr registered on 04 Oct 2018 with Charge ID 100218126 was modified on 30 Sep 2023. was documented.

  • Director Appointment

    Sumanth Karlapudi was appointed as a Director was appointed as a Director on 01 Oct 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Phanicare Pharmaceuticals Private Limited?

The CIN of Phanicare Pharmaceuticals Private Limited is U24239TG2003PTC041815.

Where is Phanicare Pharmaceuticals Private Limited headquartered?

Phanicare Pharmaceuticals Private Limited is headquartered at Unit S1, 2Nd Fllor, 36 Square Building, Jubilee Hills, Shaikpet, Telangana, 500033.

When was Phanicare Pharmaceuticals Private Limited incorporated?

Phanicare Pharmaceuticals Private Limited was incorporated on 07 October 2003.

Who are the current directors of Phanicare Pharmaceuticals Private Limited?

The current directors of Phanicare Pharmaceuticals Private Limited are

What is the primary industry of Phanicare Pharmaceuticals Private Limited?

The primary industry of Phanicare Pharmaceuticals Private Limited is Manufacturing.

Is Phanicare Pharmaceuticals Private Limited a listed company?

Phanicare Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Phanicare Pharmaceuticals Private Limited?

The authorized capital of Phanicare Pharmaceuticals Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.30 Cr.

What is the compliance status of Phanicare Pharmaceuticals Private Limited?

The compliance status of Phanicare Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available